Rodman & Renshaw Initiates Forte Biosciences(FBRX.US) With Buy Rating, Announces Target Price $4

Rodman & Renshaw analyst Elemer Piros initiates coverage on $Forte Biosciences(FBRX.US)$ with a buy rating, and sets the target price at $4.According to TipRanks data, the analyst has a success rate o

moomoo NewsJun 19 13:31 ET · Ratings

Express News | Camac Fund LP - Forte Biosciences' Board Will Be Expanded to Nine Seats, One Incumbent Director Will Resign, Two Directors Selected by Camac Fund

ReutersJun 17 06:33 ET

Express News | Camac Fund LP Says on Pursuant to Settlement Agreement Forte Biosciences Will Form Committee of Board to Explore Strategic Alternatives

ReutersJun 17 06:32 ET

Express News | Camac Fund LP Says on June 11, Entered Into Settlement Agreement With Forte Biosciences - SEC Filing

ReutersJun 17 06:30 ET

Forte Biosciences Initiated at Buy by Brookline Capital

Forte Biosciences Initiated at Buy by Brookline Capital

Dow JonesMay 30 06:06 ET

Express News | Brookline Capital Initiates Coverage On Forte Biosciences With Buy Rating, Announces Price Target of $4

BenzingaMay 30 05:56 ET